Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis ; volume:15 ; number:2 ; day:23 ; month:8 ; year:2013 ; pages:1-15 ; date:4.2013
Breast cancer research ; 15, Heft 2 (23.8.2013), 1-15, 4.2013
- Creator
-
Borges, Sahra
- Contributor
-
Döppler, Heike
Perez, Edith A.
Andorfer, Cathy A.
Sun, Zhifu
Anastasiadis, Panos Z.
Thompson, E Aubrey
Geiger, Xochiquetzal J.
Storz, Peter
SpringerLink (Online service)
- DOI
-
10.1186/bcr3460
- URN
-
urn:nbn:de:1111-2016032417519
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borges, Sahra
- Döppler, Heike
- Perez, Edith A.
- Andorfer, Cathy A.
- Sun, Zhifu
- Anastasiadis, Panos Z.
- Thompson, E Aubrey
- Geiger, Xochiquetzal J.
- Storz, Peter
- SpringerLink (Online service)
Other Objects (12)
Reversión
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Epigenetic control of pancreatic cancer metastasis
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
Reversión
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Epigenetic control of pancreatic cancer metastasis
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
Reversión
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Epigenetic silencing of MEIS2 in prostate cancer recurrence
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
Epigenetic control of pancreatic cancer metastasis
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency